Preview Mode Links will not work in preview mode

This Week in Cardiology

Jan 21, 2022

Olive oil, breastfeeding and CV health, informed consent during stroke, and controversy regarding revascularization guidelines are the topics John Mandrola, MD, covers in this week’s podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

I – Olive Oil

- Olive Oil Intake Tied to Reduced Mortality

- Consumption of Olive Oil and Risk of Total and Cause-Specific Mortality Among U.S. Adults

- Can Small Amounts of Olive Oil Keep the Death Away?

II – Breastfeeding and CV Maternal Health

- Breastfeeding Linked to Lower CVD Risk in Later Life

- Breastfeeding Is Associated With a Reduced Maternal Cardiovascular Risk: Systematic Review and Meta‐Analysis Involving Data From 8 Studies and 1 192 700 Parous Women

- Meta-analysis: pitfalls and hints

III – Informed Consent

- New Guidance on Consent in Acute Ischemic Stroke

- Consent Issues in the Management of Acute Ischemic Stroke

- The Case Against Thrombolytic Therapy in Stroke

- tPA in Stroke: 'The Facts Are Clear'

IV – Controversy in Revascularization Guidelines

- 'Incomprehensible' CABG Recommendation Raises Concerns

- Surgical Groups Push Back Against New Revascularization Guidelines

- Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

- Ten-Year Follow-Up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II)

- What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?

- Initial Invasive or Conservative Strategy for Stable Coronary Disease

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact